Jena Bioscience GmbH

Operation name
2016 FE 0061
Operation summary
LeishMEGA (Leishmania mammalian-equivalent glycosylation activity) - Creation of a new generation of LEXSY hosts with human glycosylation pattern for the production of therapeutic proteins
Operation start date
01.12.2016
Operation end date
30.11.2019
Total eligible expenditure allocated to the operation
817.497,14
Union co-financing rate
80 %
Operation postcode
07749
Country
Deutschland
Name of category of intervention
064 - Research and innovation processes in SMEs (including voucher programmes, innovations in the areas of operations, design, and service, as well as social innovations)